The Law Office of Jonathan M. Stein, P.L. is investigating the Board of Directors of American Medical Systems Holdings Inc. ("AMS" or the "Company") (Nasdaq: AMMD) for possible breaches of fiduciary duty and other violations of state law in connection with their attempt to complete a sale of the Company to Endo Pharmaceuticals Holdings, Inc. (Nasdaq: ENDP). Under the terms of the proposed transaction, AMS shareholders are to receive $30.00 in cash for each share of AMS common stock, for a total cash value of approximately $2.9 billion.
The investigation involves whether the Board of Directors of AMS breached their fiduciary duties to AMS stockholders by failing to adequately shop the Company before agreeing to enter into the transaction and whether AMS has disclosed all material information to shareholders about the proposed transaction. Specifically, over the past four months, AMS stock increased over 24% from $17.93 on November 11, 2010 to $22.33 on April 8, 2011. Further, on February 15, 2011, AMS reported “strong financial performance” and GAAP EPS of $0.35, a 16.7% increase over the prior year.
If you own stock in AMS and wish to obtain additional information about your rights, or if you have information regarding the above investigation, please contact Jonathan M. Stein, Esq. either via email at
or by telephone at (561) 961-2244.
The Law Office of Jonathan M. Stein, P.L. represents shareholders and consumers in complex litigation, including class action and derivative litigation. More information about the firm is available through its website,
, and upon request from the firm. Jonathan M. Stein is the attorney responsible for the content of this release.